Puro has announced a collaboration with Trilogene. This partnership will enable Puro to cultivate tripoid seeds.
"At Puro, we are committed to advancing the medicinal cannabis industry through innovation and sustainability," said Tom Forrest, Co-founder of Puro.
Triploid seeds represent a frontier in cannabis breeding. Unlike GMOs, triploids are developed through biotechnology techniques that combine three sets of chromosomes, enhancing their performance. This process ensures plants are non-GMO, preserving integrity while unlocking benefits, including pollen tolerance, improved ability to handle abiotic stress, and superior profiles. These traits make triploids ideal for large-scale production.
For more information:
Puro
www.puro.co.nz